CXCL13 was over-production within the central nervous system (CNS) of CNS lymphoma patients, studies suggested that CXCL13 may as a potential biomarker of CNS lymphoma [28, 29]. The gene discussed is CXCL13; the disease is primary central nervous system lymphoma.